| Literature DB >> 27338315 |
Zhipan Wu1, Rongfa Guan2, Fei Lyu3, Mingqi Liu4, Jianguo Gao5, Guozou Cao6.
Abstract
The main purpose of this study was to optimize the preparation of lysozyme nanoliposomes using response surface methodology and measure their stability. The stabilities of lysozyme nanoliposomes in simulated gastrointestinal fluid (SGF), simulated intestinal fluid (SIF), as well as pH, temperature and sonication treatment time were evaluated. Reverse-phase evaporation method is an easy, speedy, and beneficial approach for nanoliposomes' preparation and optimization. The optimal preparative conditions were as follows: phosphatidylcholine-to-cholesterol ratio of 3.86, lysozyme concentration of 1.96 mg/mL, magnetic stirring time of 40.61 min, and ultrasound time of 14.15 min. At the optimal point, encapsulation efficiency and particle size were found to be 75.36% ± 3.20% and 245.6 nm ± 5.2 nm, respectively. The lysozyme nanoliposomes demonstrated certain stability in SGF and SIF at a temperature of 37 °C for 4 h, and short sonication handling times were required to attain nano-scaled liposomes. Under conditions of high temperature, acidity and alkalinity, lysozyme nanoliposomes are unstable.Entities:
Keywords: lysozyme; nanoliposomes; optimization; response surface methodology; stability
Mesh:
Substances:
Year: 2016 PMID: 27338315 PMCID: PMC6273706 DOI: 10.3390/molecules21060741
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
ANOVA and regression coefficients of the second-order polynomial model for the response variable (actual value).
| Source | DF | EE% | ||
|---|---|---|---|---|
| Coefficient | Sum of Squares | |||
| Model | 14 | 76.56 | 3098.91 | <0.0001 |
| Linear | ||||
| X1 | 1 | −2.58 | 80.08 | 0.0069 |
| X2 | 1 | −0.34 | 1.40 | 0.6823 |
| X3 | 1 | −4.73 | 268.85 | <0.0001 |
| X4 | 1 | 3.46 | 143.52 | 0.0008 |
| Quadratic | ||||
| X12 | −8.38 | 455.51 | <0.0001 | |
| X22 | −9.84 | 628.38 | <0.0001 | |
| X32 | −14.63 | 1388.35 | <0.0001 | |
| X42 | −14.47 | 1357.68 | <0.0001 | |
| Interaction | ||||
| X1X2 | −0.55 | 1.21 | 0.7035 | |
| X1X3 | −0.25 | 0.25 | 0.8624 | |
| X1X4 | 1.75 | 12.25 | 0.2367 | |
| X2X3 | 1.73 | 11.90 | 0.2432 | |
| X2X4 | −1.35 | 7.29 | 0.3565 | |
| X3X4 | −1.63 | 10.56 | 0.2703 | |
| Residual | 14 | 112.24 | ||
| Lack of fit | 10 | 92.76 | 0.2797 | |
| Pure error | 4 | 19.47 | ||
| Total | 28 | 3211.15 | ||
| R2 | 0.9650 | |||
| Adj-R2 | 0.9301 | |||
| CV | 4.97 | |||
Figure 1Response surface figures with the influence of the independent variables on encapsulation efficiency of lysozyme nanoliposomes. The effects of phosphatidylcholine-to-cholesterol ratio and magnetic stirring time are shown in (A) (ultrasound time = 15 min and lysozyme concentration = 2 mg/mL); the effects of magnetic stirring time and ultrasound time are shown in (B) (phosphatidylcholineto-cholesterol ratio = 4 and lysozyme concentration = 2 mg/mL).
Figure 2The particle size of the optimized lysozyme nanoliposomes.
Figure 3The morphology of the optimized lysozyme nanoliposomes.
Figure 4The effect of release ratio on lysozyme nanoliposomes under different pH.
Figure 5The effect of release ratio on lysozyme nanoliposomes at different temperatures.
Figure 6The effect of release ratio on lysozyme nanoliposomes at different ultrasound times.
Figure 7The effect of SGF and SIF on nanoliposomes.
Independent variables and their levels in the experimental design.
| Independent Variables | Symbols | Code Levels | ||
|---|---|---|---|---|
| −1 | 0 | 1 | ||
| PC/CH ( | X1 | 3 | 4 | 5 |
| Lysozyme concentration ( | X2 | 1 | 2 | 3 |
| Ultrasound time (min) | X3 | 10 | 15 | 20 |
| Magnetic stirring time (min) | X4 | 35 | 40 | 45 |